[HTML][HTML] Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis
…, A Karras, C Khouatra, O Aumaître… - … England Journal of …, 2014 - Mass Medical Soc
Background The combination of cyclophosphamide and glucocorticoids leads to remission
in most patients with antineutrophil cytoplasm antibody (ANCA)–associated vasculitides. …
in most patients with antineutrophil cytoplasm antibody (ANCA)–associated vasculitides. …
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis …
…, B Bienvenu, X Puéchal, O Aumaître… - Arthritis & …, 2013 - Wiley Online Library
Objective Earlier studies of eosinophilic granulomatosis with polyangiitis (Churg‐Strauss) (EGPA),
with limited patient numbers and followup durations, demonstrated that clinical …
with limited patient numbers and followup durations, demonstrated that clinical …
[HTML][HTML] Multiple phenotypes in phosphoglucomutase 1 deficiency
…, T Stojkovic, P Laforêt, F Petit, O Aumaître… - … England Journal of …, 2014 - Mass Medical Soc
Background Congenital disorders of glycosylation are genetic syndromes that result in
impaired glycoprotein production. We evaluated patients who had a novel recessive disorder of …
impaired glycoprotein production. We evaluated patients who had a novel recessive disorder of …
Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up
…, P Ghillani, L Galicier, O Aumaître… - Lupus science & …, 2014 - lupus.bmj.com
Objectives Growing evidence suggests that vitamin D plays a key role in the pathogenesis
and progression of autoimmune diseases, including systemic lupus erythematosus (SLE). …
and progression of autoimmune diseases, including systemic lupus erythematosus (SLE). …
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised …
…, G Pugnet, M Matignon, O Aumaitre… - Annals of the …, 2018 - ard.bmj.com
Objective To compare individually tailored, based on trimestrial biological parameter
monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of antineutrophil …
monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of antineutrophil …
Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature
JF Dufour, T Le Gallou, JF Cordier, O Aumaître… - Medicine, 2012 - journals.lww.com
We describe the main characteristics and treatment of urogenital manifestations in patients
with Wegener granulomatosis (WG). We conducted a retrospective review of the charts of 11 …
with Wegener granulomatosis (WG). We conducted a retrospective review of the charts of 11 …
Rituximab vs cyclophosphamide induction therapy for patients with granulomatosis with polyangiitis
…, T Quéméneur, A Aouba, O Aumaître… - JAMA Network …, 2022 - jamanetwork.com
Importance Results of randomized clinical trials have demonstrated rituximab’s noninferiority
to cyclophosphamide as induction therapy for antineutrophil cytoplasm antibody (ANCA)–…
to cyclophosphamide as induction therapy for antineutrophil cytoplasm antibody (ANCA)–…
Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature
…, PJ Wismans, H Rousset, JF Colombel, O Aumaître… - Medicine, 2007 - journals.lww.com
Aseptic abscesses (AA) are characterized by deep, sterile, round lesions consisting of
neutrophil that do not respond to antibiotics but improve dramatically with corticosteroids. We …
neutrophil that do not respond to antibiotics but improve dramatically with corticosteroids. We …
Temporal arteritis revealing antineutrophil cytoplasmic antibody–associated vasculitides: a case–control study
…, E Lazaro, L Mouthon, O Aumaître… - Arthritis & …, 2021 - Wiley Online Library
Objective Temporal arteritis (TA) is a typical manifestation of giant cell arteritis (GCA).
Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides (AAVs) are rarely revealed by …
Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides (AAVs) are rarely revealed by …
ANCA-associated vasculitides: recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction …
B Terrier, P Charles, O Aumaître, A Belot, B Bonnotte… - La Presse Médicale, 2020 - Elsevier
Abstract Treatment of vasculitides associated with anti-neutrophil cytoplasm antibodies (ANCA)
(AAVs) has evolved dramatically in recent years, particularly since the demonstration of …
(AAVs) has evolved dramatically in recent years, particularly since the demonstration of …